정석재 교수
Suk-Jae Jeong
서울대학교 의약학과 · 의학
연구실 소개
정석재 교수의 연구실은 약물 대사 및 전달, 특히 약물 운반체와 약물 상호작용에 초점을 맞춘 약리학 및 약동학 분야의 연구를 수행하고 있습니다. BCRP 등 약물 운반체의 기능 조절, 신약 후보 물질의 체내 행동 예측을 위한 생리기반 약동학 모델링, 그리고 나노입자나 약물의 생체 내 운반 경로 분석을 통해 약물의 뇌전달 효율을 높이는 데 기여하고 있습니다. 특히 약물 상호작용의 기전 규명과 임상 적용 가능성을 고려한 정밀한 분석 기법 개발에도 주력하고 있습니다.
연구 현황
연구 성과 추이
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
주요 논문
15The potential inhibitory effect of quercetin, a major plant flavonol, on breast cancer resistance protein (BCRP) activity was investigated in this study. The presence of quercetin significantly increased the cellular accumulation and associated cytotoxicity of the BCRP substrate mitoxantrone in human cervical cancer cells (HeLa cells) in a concentration-dependent manner. The transcellular efflux of prazosin, a stereotypical BCRP substrate, was also significantly reduced in the presence of querce
Fexuprazan is a new drug candidate in the potassium-competitive acid blocker (P-CAB) family. As proton pump inhibitors (PPIs), P-CABs inhibit gastric acid secretion and can be used to treat gastric acid-related disorders such as gastroesophageal reflux disease (GERD). Physiologically based pharmacokinetic (PBPK) models predict drug interactions as pharmacokinetic profiles in biological matrices can be mechanistically simulated. Here, we propose an optimized and validated PBPK model for fexupraza
The objectives of this study were to evaluate the relative contribution of the direct pathway in overall brain transport for 17 model drugs with different physicochemical properties after nasal administrations and to identify factors that govern the fraction of the dose transported to the brain via the direct pathway (F(a, direct)). When the model drugs were nasally administered to rats, 5 of the 17 model drugs were delivered to a significant extent to the brain via the direct pathway. Multiple
A single-dose glass ampoule was developed for ease of administration. When glass ampoules are opened, resulting in contamination by particulate matter. Reducing its contamination may minimize the risk in patients due to particulates. This study reports on an attempt to reduce insoluble particulate contamination by developing methods for the precise measurement of this. A vacuum machine (VM) was used to reduce the level of insoluble particulate contamination, and a microscopy, scanning electron m
A liquid chromatography-mass spectrometry (LC-MS) assay was developed and validated for the quantification of cilnidipine, a calcium channel antagonist, in human plasma. Plasma samples were processed by liquid-liquid extraction and the analyte, along with nimodipine (an internal standard), and analyzed using selected ion monitoring (SIM) for detection. The absolute extraction recovery was determined to be not less than 89.1% for various concentrations. The detector response was specific and line
대표 연구 분야
정석재 교수의 연구를 Nubint에서 더 깊이 살펴보세요
이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.